Anixa Biosciences, Inc.
NASDAQANIX heads into the final days of April trading at $2.88 — down 8% on the week and 4% on Wednesday alone — even as the company secured a fresh patent win for its breast cancer vaccine technology in Mexico. The contrast is the week's defining tension. On April 29, the Mexican Institute of Industrial Property granted Anixa Biosciences a patent covering its breast cancer vaccine…
Snapshot as of 10 May 2026
ANIX heads into the final days of April trading at $2.88 — down 8% on the week and 4% on Wednesday alone — even as the company secured a fresh patent win for its breast cancer vaccine technology in Mexico. The contrast…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ANIX — free to start on ORTEX.
Sign up for free →Open ANIX on ORTEX